THE ROLE OF BLOOD COMPONENT THERAPY IN THE MANAGEMENT OF CANINE AND FELINE PATIENTS WITH CANCER

Authors
RUDLOFF E
Citation
E. Rudloff, THE ROLE OF BLOOD COMPONENT THERAPY IN THE MANAGEMENT OF CANINE AND FELINE PATIENTS WITH CANCER, The Veterinary clinics of North America. Small animal practice, 25(6), 1995, pp. 1403
Citations number
75
Categorie Soggetti
Veterinary Sciences
Journal title
The Veterinary clinics of North America. Small animal practice → ACNP
ISSN journal
01955616
Volume
25
Issue
6
Year of publication
1995
Database
ISI
SICI code
0195-5616(1995)25:6<1403:TROBCT>2.0.ZU;2-3
Abstract
Blood component therapy may be required for a variety of pathologic re asons in the cancer patient. The tumor itself not only affects various cell lines, but treatment with chemotherapeutic agents can induce cyt openias. In addition, chronic or acute hemorrhage can be caused by tum or erosion and rupture or by paraneoplastic coagulopathies. Component replacement will depend on the underlying hematologic deficiencies and should be performed in conjunction with treating the cause of the def iciency.